Indiana Organizations Launch Provena Consortium for Clinical and Genomic Data Resource
A coalition of Indiana-based organizations has launched the Provena Consortium, a new clinical and genomic data resource. This consortium connects academic and industry researchers with genomic data linked to longitudinal clinical data from over 90,000 consented participants. These participants have also agreed to be re-contacted for future studies. The founding partners include Eli Lilly and Co., Indiana University Health (IU Health), Indiana University (IU), the Indiana Health Information Exchange, the CEOs of Indiana Corporate Partnership (CICP), the Indiana Biosciences Research Institute, Purdue University, and the Regenstrief Institute. The consortium is expanding rapidly, adding over 3,500 participants each month, with a goal to reach 250,000 genotyped, clinically characterized, and recallable participants. This initiative is supported by grants from Lilly Endowment Inc. and a significant investment from IU, including $6.8 million for advanced sequencing equipment and infrastructure.